location_onSan Francisco, CA, USA
watch_later Posted: Feb 26, 2025
Job Description
The Company
89bio is a clinical-stage biopharmaceutical company dedicated to the development of best-in-class therapies for patients with liver and cardiometabolic diseases who lack optimal treatment options. The company is focused on rapidly advancing its lead candidate, pegozafermin, through Phase 3 clinical development for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and severe hypertriglyceridemia (SHTG). Pegozafermin is a specifically engineered, potentially best-in-class fibroblast growth factor 21 (FGF21) analog with unique glycoPEGylated technology that optimizes biological activity through an extended half-life. The company is headquartered in San Francisco.
THE ROLE
The Clinical Science/Development internship will offer hands-on experience in a global Phase 3 clinical trial setting. As an intern, you will perform in-depth data analyses across multiple datasets (e.g., enrollment trends, adverse events, baseline characteristics) to uncover and address potential risks in drug development.
You will have the opportunity to develop and refine your data analysis skills (using R, Python, Excel, Prism, and more) while learning to communicate technical insights to diverse audiences-ranging from dynamic study teams to key opinion leaders in the field. In addition, you will be exposed to various trial designs, trial execution strategies, and gain insight into the biology of metabolic liver diseases, preparing you for a future in clinical development.
PROGRAM HIGHLIGHTS
This is a (40 hours/week) paid internship lasting 8 weeks over the 2025 Summer.
Pay will be commensurate with level (undergrad/graduate)
All qualified applicants will receive consideration for employment without regard to race, sex, color, religion, sexual orientation, gender identity, national origin, protected veteran status, or based on disability.
89bio is a clinical-stage biopharmaceutical company dedicated to the development of best-in-class therapies for patients with liver and cardiometabolic diseases who lack optimal treatment options. The company is focused on rapidly advancing its lead candidate, pegozafermin, through Phase 3 clinical development for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and severe hypertriglyceridemia (SHTG). Pegozafermin is a specifically engineered, potentially best-in-class fibroblast growth factor 21 (FGF21) analog with unique glycoPEGylated technology that optimizes biological activity through an extended half-life. The company is headquartered in San Francisco.
THE ROLE
The Clinical Science/Development internship will offer hands-on experience in a global Phase 3 clinical trial setting. As an intern, you will perform in-depth data analyses across multiple datasets (e.g., enrollment trends, adverse events, baseline characteristics) to uncover and address potential risks in drug development.
You will have the opportunity to develop and refine your data analysis skills (using R, Python, Excel, Prism, and more) while learning to communicate technical insights to diverse audiences-ranging from dynamic study teams to key opinion leaders in the field. In addition, you will be exposed to various trial designs, trial execution strategies, and gain insight into the biology of metabolic liver diseases, preparing you for a future in clinical development.
PROGRAM HIGHLIGHTS
- Position is located in San Francisco, on-site, two days a week (Tuesdays and Wednesdays) and remote the rest of the week
- Intensive, 8-weeks, paid internship
- June/August Program Dates
- Work with some of the most talented people in biotechnology industry
- Enrolled in an accredited college/university pursuing the following degrees: Any biology (molecular, chemistry, environmental, bioengineering) or health care related field. MD-PhD students are highly encouraged.
- Be legally authorized to work in the United States
- Experience with R and machine learning highly preferred.
- Background investigations are required for all positions by 89bio, consistent with applicable law.
This is a (40 hours/week) paid internship lasting 8 weeks over the 2025 Summer.
Pay will be commensurate with level (undergrad/graduate)
All qualified applicants will receive consideration for employment without regard to race, sex, color, religion, sexual orientation, gender identity, national origin, protected veteran status, or based on disability.
Disclaimer: The jobs on Lifelancer Platform are posted by employers, recruiters and Lifelancer. We aim to provide value to Talent users by connecting them with a maximum number of curated job opportunities. However, Lifelancer doesn't represent job-offering companies and is not responsible for job advert content or updates. We aim to connect you with the employer, job source, or application link to the best of our ability. You can apply for this job on the company website.